EP0750495B1 — Use of a lipophilic surfactant in a pharmaceutical composition
Assigned to RP Scherer Technologies LLC · Expires 2002-12-04 · 23y expired
What this patent protects
A carrier system for a hydrophobic drug comprises (a) a digestible oil, and (b) a pharmaceutically acceptable surfactant for dispersing the oil in vivo upon administration of the carrier system. The surfactant comprises a hydrophilic surfactant component, such as a transester…
USPTO Abstract
A carrier system for a hydrophobic drug comprises (a) a digestible oil, and (b) a pharmaceutically acceptable surfactant for dispersing the oil in vivo upon administration of the carrier system. The surfactant comprises a hydrophilic surfactant component, such as a transesterification product of polyethylene glycol and glycerol esters of capric and caprylic acids, which does not substantially inhibit the lipolysis of the digestible oil.
Drugs covered by this patent
- Estrace (ESTRADIOL) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.